Effect of androgen therapy and anemia on
β
Piedras, Josefa; HernΓ‘ndez, Guadalupe; LΓ³pez-Karpovitch, Xavier
π
Article
π
1998
π
John Wiley and Sons
π
English
β 53 KB
π 2 views
Immunoreactive serum erythropoietin (EPO) was measured in anemic and non-anemic patients with acquired non-severe aplastic anemia (AA; n = 22) and myelodysplastic syndromes (MDS; n = 31) receiving or not androgens to examine the effect of androgen therapy and anemia on EPO levels in these disorders.